Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Long-CoviD Patients Causal Diagnosis and Rehabilitation Randomized Feasibility Controlled Trial in Patients With Dysautonomia: the LoCoDiRe-Dys Study

NCT05855356 is registered in ClinicalTrials.gov with Evangelismos Hospital as lead sponsor.

NCT NCT05855356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05855356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Long-CoviD Patients Causal Diagnosis and Rehabilitation Randomized Feasibility Controlled Trial in Patients With Dysautonomia: the LoCoDiRe-Dys Study
Lead sponsor
Evangelismos Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
February 1, 2023
Completion date
March 27, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dysautonomia, post-acute covid-19 syndrome